These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3040609)

  • 1. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
    Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM
    Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
    Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ
    Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cyclic 3',5'-nucleotide phosphodiesterase in patients with various thyroid disorders.
    Nagasaka A; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M; Nihei N; Nakagawa H; Ohyama T; Aono T
    Enzyme; 1985; 33(1):18-24. PubMed ID: 2985379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylethanolamine methyltransferase and cAMP, cGMP phosphodiesterases in lymphocytes and monocytes in sarcoidosis.
    Pacheco Y; Dubois M; Prigent AF; Fonlupt P; Timouyasse L; Rey C; Chambe MT; Biot N; Perrin-Fayolle M; Pacheco H
    Clin Chim Acta; 1987 Mar; 163(3):267-77. PubMed ID: 3034451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
    Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
    Naskalski JW; Uciński WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.
    Tenor H; Staniciu L; Schudt C; Hatzelmann A; Wendel A; Djukanović R; Church MK; Shute JK
    Clin Exp Allergy; 1995 Jul; 25(7):616-24. PubMed ID: 8521180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes.
    Wedner HJ
    Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils.
    Grady PG; Thomas LL
    Biochim Biophys Acta; 1986 Mar; 885(3):282-93. PubMed ID: 3004603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP metabolism in peripheral blood lymphocytes from patients with Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1389-92. PubMed ID: 6094195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
    Taylor PM; Heptinstall S
    Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease.
    Aleksijevic A; Lang JM; Giron C; Stoclet JC; Mayer S; Oberling F
    Clin Immunol Immunopathol; 1983 Mar; 26(3):398-405. PubMed ID: 6307567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
    Grant PG; Mannarino AF; Colman RW
    Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
    Uciński WS; Naskalski JW
    Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
    Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
    Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 18. S-100 antigen and calmodulin in human leukemic cells.
    Wada H; Shirakawa S; Yamakado T; Ohkubo S; Tanaka T; Yamamoto T; Hidaka H
    Leuk Res; 1989; 13(1):65-9. PubMed ID: 2536871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
    Killackey JJ; Killackey BA; Philp RB
    Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
    Kurokawa Y; Fukuda I; Mozai T
    Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.